title: Psoriasis as a Manifestation of an Immune Reconstitution in Two Patients with Hepatitis C Treated with Ledipasvir/Sofosbuvir.
authors.affiliation: Department of Dermatology, University Hospital of Erlangen, Ulmenweg 18, DE-91054 Erlangen, Germany. franz.heppt@uk-erlangen.de.
authors.forename: Franz
authors.initials: F
authors.lastname: Heppt
authors.forename: Michael
authors.initials: M
authors.lastname: Sticherling
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D018450:Disease Progression; D005449:Fluorenes / Q000009:adverse effects*; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D012307:Risk Factors; D012720:Severity of Illness Index; D000069474:Sofosbuvir; D016896:Treatment Outcome; D014467:Ultraviolet Therapy; D014542:Uridine Monophosphate / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D003879:Dermatologic Agents; D005449:Fluorenes; C000595958:ledipasvir, sofosbuvir drug combination; D014542:Uridine Monophosphate; D000069474:Sofosbuvir